PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
322,000
-3,000 (-0.92%)
Apr 29, 2026, 3:30 PM KST

PharmaResearch Revenue

In the year 2025, PharmaResearch had annual revenue of 536.29B KRW with 53.18% growth. PharmaResearch had revenue of 143.35B in the quarter ending December 31, 2025, with 39.06% growth.

Revenue
536.29B
Revenue Growth
+53.18%
P/S Ratio
6.30
Revenue / Employee
1.08B
Employees
497
Market Cap
3,376.64B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025536.29B186.17B53.18%
Dec 31, 2024350.12B89.10B34.14%
Dec 31, 2023261.01B66.25B34.02%
Dec 31, 2022194.76B40.68B26.40%
Dec 31, 2021154.08B45.34B41.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SK bioscience 651.37B
D&D Pharmatech 4.30B
Hugel 425.11B
OliX Pharmaceuticals 14.67B
Voronoi 7.51B
Orum Therapeutics 23.56M
Peptron 5.63B
Chabiotech 1,268.25B
Revenue Rankings